S1. Rituximab for ANCA-associated vasculitis

The experience in the United States

Jeremy M. Clain, Ulrich Specks

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)530-532
Number of pages3
JournalPresse Medicale
Volume42
Issue number4 PART2
DOIs
StatePublished - Apr 2013

Fingerprint

Murine-Derived Monoclonal Antibodies
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Churg-Strauss Syndrome
Drug Approval
Granulomatosis with Polyangiitis
Antirheumatic Agents
United States Food and Drug Administration
Combination Drug Therapy
Cyclophosphamide
Glucocorticoids
Rituximab

ASJC Scopus subject areas

  • Medicine(all)

Cite this

S1. Rituximab for ANCA-associated vasculitis : The experience in the United States. / Clain, Jeremy M.; Specks, Ulrich.

In: Presse Medicale, Vol. 42, No. 4 PART2, 04.2013, p. 530-532.

Research output: Contribution to journalArticle

@article{b9737e12baf6412599c25803e148d162,
title = "S1. Rituximab for ANCA-associated vasculitis: The experience in the United States",
author = "Clain, {Jeremy M.} and Ulrich Specks",
year = "2013",
month = "4",
doi = "10.1016/j.lpm.2013.01.048",
language = "English (US)",
volume = "42",
pages = "530--532",
journal = "Presse Medicale",
issn = "0755-4982",
publisher = "Elsevier Masson",
number = "4 PART2",

}

TY - JOUR

T1 - S1. Rituximab for ANCA-associated vasculitis

T2 - The experience in the United States

AU - Clain, Jeremy M.

AU - Specks, Ulrich

PY - 2013/4

Y1 - 2013/4

UR - http://www.scopus.com/inward/record.url?scp=84875605046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875605046&partnerID=8YFLogxK

U2 - 10.1016/j.lpm.2013.01.048

DO - 10.1016/j.lpm.2013.01.048

M3 - Article

VL - 42

SP - 530

EP - 532

JO - Presse Medicale

JF - Presse Medicale

SN - 0755-4982

IS - 4 PART2

ER -